Weill Cornell pharmacologist receives prestigious NIH M...( $2.5 million grant supports research ...)

Weill Cornell pharmacologist receives prestigious NIH MERIT Award

$2.5 million grant supports research into potential pharmaceutical targets for treating vascular complications of diabetes

NEW YORK (May 21, 2007) -- A leading authority and pioneer in the pharmacology of the signaling molecule nitric oxide (NO), Weill Cornell Medical College scientist Dr. Steven S. Gross has been selected by the National Heart, Lung, and Blood Institute (NHLBI) to receive a 2007 National Institutes of Health (NIH) Method to Extend Research in Time (MERIT) Award, representing the fourth year the College has been selected for the prestigious honor.

This year's $2.5 million five-year research grant will provide long-term support for research aimed at furthering understanding of the NO-related trigger for vascular complications of diabetes and developing novel pharmaceutical approaches for ameliorating the condition.

Dr. Gross is professor of pharmacology, director of the mass spectrometry core facility and principal investigator on an NIH grant that supports the training of Ph.D. candidates in the Graduate School Program in Pharmacology at Weill Cornell Medical College.

"We are extremely grateful for the NIH's continued support for our translational research efforts," says Dr. Antonio M. Gotto Jr., the Stephen and Suzanne Weiss Dean of Weill Cornell Medical College. "Dr. Gross is highly deserving of this honor. His research has uncovered a wealth of information about the important role of nitric oxide in the body. This work, which has laid the groundwork for treatments of numerous disease conditions that have been attributed to nitric oxide excess or insufficiency, is currently focused on new approaches for one of the most painful complications of diabetes."

Beginning in the late 1980s, Dr. Gross and colleagues made several key discoveries about nitric oxide. Working with Dr. Roberto Levi and colleagues at Weill Cornell, Dr. Gross was a member of the first group to administer a selective inh
'"/>

Contact: Andrew Klein
ank2017@med.cornell.edu
212-821-0560
New York- Presbyterian Hospital/Weill Cornell Medical Center/Weill Cornell Medical College
21-May-2007

Page: 1 2 3 4
Related biology news :

1. Weill Cornell team identifies potential new cancer drug target
2. Stem cell research at Weill Cornell, The Rockefeller University, and Sloan-Kettering
3. Weill Cornell team develops fast-acting anthrax vaccine
4. Cornell scientists link E. coli bacteria to Crohns disease
5. Methodist, University of Houston, Cornell combine biomedical imaging expertise
6. Cornell lab confirms deadly fish virus spreading to new species
7. NSF awards $3.3 million grant to Cornell to bolster the percentage of women faculty members
8. Cornell researchers find serious fish virus in Northeast for first time
9. Cornell finds natural selection in humans
10. Northeast Sun Grant Institute at Cornell spurs green revolution
11. Cornell graduate student named 2005 AIBS Emerging Public Policy Leader

Post Your Comments:

(Date:11/22/2009)...herited gene deletion can increase the likelihood ...splantation, an international team of researchers ... Nature Genetics . When the gene, called UGT2B17,... the recipient,s, transplants have a significantly...aft-versus-host disease, in which immune cells fro...

(Date:11/22/2009)... the Brain Research Centre, a partnership of the U...and Vancouver Coastal Health Research Institute, h...by which brain cells die following a stroke, as we...results of the study were recently published onlin...ny brain cells continue to die even after blood fl...

(Date:11/20/2009)... report published in the November 2009 issue of th...scientists show how a family of genes (1-aminocycl... responsible for production of ethylene. This gas ...s information lays the foundation for future genet...istant, able to survive and thrive in difficult te...

Breaking Biology News(10 mins):Gene mismatch influences success of bone marrow transplants 2 Gene mismatch influences success of bone marrow transplants 3 Gene mismatch influences success of bone marrow transplants 4 New understanding about mechanism for cell death after stroke leads to possible therapy 2 It's a gas: New discovery may lead to heartier, high-yielding plants 2 Cellzome Technology Used to Unravel Novel Regulatory Mechanism in Cancer Signaling Pathway 14104 1 Cellzome Technology Used to Unravel Novel Regulatory Mechanism in Cancer Signaling Pathway 14104 2 Scars of Bullying Linger 57417 1 Forman Perry Watkins Krutz 26 Tardy Announces Take Nothing Verdict in Mississippi Asbestos Exposure Trial 57412 1 Forman Perry Watkins Krutz 26 Tardy Announces Take Nothing Verdict in Mississippi Asbestos Exposure Trial 57412 2

[0] Gene mismatch influences success of bone marrow transplants [0] New understanding about mechanism for cell death after stroke leads to possible therapy [0] It's a gas: New discovery may lead to heartier, high-yielding plants

(Date:11/23/2009)... Contec’s Sporicidin disinf...ve hospital-grade disinfectants against H1N1 and I...g, SC (PRWEB) November 24, 2009 -- Contec Inc, the...s announced that their Sporicidin disinfectants ...ll Influenza A viruses, including Pandemic 2009 H1...

(Date:11/23/2009)...MOUNTAINVIEW,Calif.,Nov.23/PRNewswire/--Frost&...carecompaniesfordemonstratingleadershipandinnovati...areInnovationAwardsBanquetheldinSanAntonio,Texas. ...0081117/FSLOGO ) ,, TheHealthcareInnovationAwar...ibutiontothedeliveryandmanagementofhealthcare.Such...

(Date:11/20/2009)..., , , , , , , ,... , AUDIO: , A team of scientists fro...ty of Arizona, Cold Spring Harbor Laboratory and I...NA of corn. The... , , Click here... , , , , , , , ...

(Date:11/20/2009)..., SEATTLE, Nov. 20 Den... that the U.S. Food and Drug Administration (FDA) ...s amended Biologics License Application (BLA) for ...se. The FDA has assigned a Prescription Drug User...e it will respond to Dendreon,s amended BLA. Dend...

Breaking Biology Technology:Sporicidin Brand Disinfectant Kills H1N1 in 3 Minutes 2 Excellence in Healthcare Innovation Recognized by Frost & Sullivan 2 Excellence in Healthcare Innovation Recognized by Frost & Sullivan 3 Amaizing: Corn genome decoded 2 Amaizing: Corn genome decoded 3 Amaizing: Corn genome decoded 4 Dendreon Receives FDA Acknowledgement of Complete Response 2 Dendreon Receives FDA Acknowledgement of Complete Response 3

[0] Sporicidin Brand Disinfectant Kills H1N1 in 3 Minutes [0] Excellence in Healthcare Innovation Recognized by Frost & Sullivan [1] Amaizing: Corn genome decoded [0] Dendreon Receives FDA Acknowledgement of Complete Response

Other News:

A summer voyage to investigate the causes of one of the most devastating tsunamis in United States history has uncovered new mysteries about biological and geological processes off Alaska.......Probin

...nstitute of Oceanography in Savannah have offered ... blue crab population that has devastated one of t........In an article in the November/December issue ... E. Frischer, working on a grant from the Georgia ...

...rlier this month in Kansas is showing signs of rec...treating the bird at the USGS Patuxent Wildlife Re...o know whether it will be able to return to the wi... wild flock of an endangered species that migrates...

...ine being able to see or taste sounds, as well as ...me people, it's reality.......This blending of the...esia." In this condition, a stimulus, such as sou...s the expected sense.......Now, professor Daphne M...

Researchers probe marine mysteries off the Alaskan coast 2 Researchers probe marine mysteries off the Alaskan coast 3 UGA researchers explain recent decline in Georgia's blue crab population 2 Injured whooping crane recovering at USGS Patuxent Wildlife Research Center 2

Researchers probe marine mysteries off the Alaskan coast UGA researchers explain recent decline in Georgia's blue crab population Injured whooping crane recovering at USGS Patuxent Wildlife Research Center What colour is that sound?

...DGE, Tenn., July 23, 2002 - Oak Ridge National Lab...ergy awards for the Genomes to Life program and wi...e effort that promises payoffs for energy and envi...o Life program, researchers hope to identify and c...

...chers at the University of California, San Diego (... between proteins that is an essential part of the...mal eye development in mice. The investigators al...ns in eye formation may be similar to yet unidenti...

...ernational team of researchers that is publishing ...c profiling of any organism, in this case yeast, w...ng the basic functions of human cells. ......The J...udes an article entitled, "Functional profiling of...

YOUNG men are often risk takers, and their predilection for thrills and spills means that they are more likely to die than young women. But if you assume things even out in later life, think again. Ev

ORNL receives $21.7 million for DOE's Genomes to Life 2 ORNL receives $21.7 million for DOE's Genomes to Life 3 UCSD researchers identify eye-formation strategy in mice 2 Men die young, even when they're old 2

ORNL receives $21.7 million for DOE's Genomes to Life UCSD researchers identify eye-formation strategy in mice Breakthrough in profiling of yeast genome Men die young, even when they're old